Literature DB >> 16884713

Fibroblast growth factor-2 induces the activation of Src through Fes, which regulates focal adhesion disassembly.

Shigeru Kanda1, Yasuyoshi Miyata, Hiroshi Kanetake, Thomas E Smithgall.   

Abstract

Cell migration is regulated by focal adhesion (FA) turnover. Fibroblast growth factor-2 (FGF-2) induces FA disassembly in the murine brain capillary endothelial cell line IBE, leading to FGF-2-directed chemotaxis. We previously showed that activation of Src and Fes by FGF-2 was involved in chemotaxis of IBE cells. In this study, we examined the interplay between Src and Fes. FGF-2 treatment decreased the number of FA in IBE cells, but not in cells expressing dominant-negative Fes (denoted KE5-15 cells). FGF-2 induced the activation of Src and subsequent binding to and phosphorylation of Cas in IBE cells, but not in KE5-15 cells. Focal adhesion kinase (FAK) activation and tyrosine phosphorylation by Src were also delayed in KE5-15 cells compared to parental cells. FGF-2 induced activation of Src within FA in IBE cells, but not in KE5-15 cells. Downregulation of Fes or FAK using small interfering RNA diminished Src activation by FGF-2 within FA. These findings suggest that activation of Fes by FGF-2 enhances FAK-dependent activation of Src within FA, promoting FGF-2-induced disassembly of focal adhesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884713     DOI: 10.1016/j.yexcr.2006.06.032

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis.

Authors:  Xinhai Yang; Dianhua Qiao; Kristy Meyer; Andreas Friedl
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

2.  Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting.

Authors:  Resham Bhattacharya; Junhye Kwon; Xiujuan Li; Enfeng Wang; Sujata Patra; John Paul Bida; Zeljko Bajzer; Lena Claesson-Welsh; Debabrata Mukhopadhyay
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

3.  Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells.

Authors:  Shigeru Kanda; Yasuyoshi Miyata; Hiroshi Kanetake; Thomas E Smithgall
Journal:  Int J Oncol       Date:  2009-01       Impact factor: 5.650

4.  Long-term exposure of human renal carcinoma cells to PD98059 induces epithelial-mesenchymal transition-like phenotype and enhanced motility.

Authors:  Shigeru Kanda; Hiroshi Kanetake; Yasuyoshi Miyata
Journal:  Mol Cell Biochem       Date:  2007-11-14       Impact factor: 3.396

5.  Spatial recruitment and activation of the Fes kinase by ezrin promotes HGF-induced cell scattering.

Authors:  Alexandra Naba; Céline Reverdy; Daniel Louvard; Monique Arpin
Journal:  EMBO J       Date:  2007-11-29       Impact factor: 11.598

6.  Loss of PTEN function may account for reduced proliferation pathway sensitivity to LY294002 in human prostate and bladder cancer cells.

Authors:  Shigeru Kanda; Hiroshi Kanetake; Yasuyoshi Miyata
Journal:  J Cancer Res Clin Oncol       Date:  2008-08-23       Impact factor: 4.553

7.  Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope.

Authors:  Jennifer M Caron; Jacquelyn J Ames; Liangru Contois; Leonard Liebes; Robert Friesel; Franco Muggia; Calvin P H Vary; Leif Oxburgh; Peter C Brooks
Journal:  Am J Pathol       Date:  2016-06       Impact factor: 4.307

8.  Downregulation of Fes inhibits VEGF-A-induced chemotaxis and capillary-like morphogenesis by cultured endothelial cells.

Authors:  Shigeru Kanda; Hiroshi Kanetake; Yasuyoshi Miyata
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.